Where to Have Follow-up Checkups After Returning from IVF in Thailand? Domestic Hospital Selection and Process
AI Summary
A 38-year-old patient returned home on the 5th day after completing an embryo transfer in Thailand. Her first call after landing was to the clinic: "Which hospital should I go to for my next checkup? Can the gynecology department at the local tertiary hospital do it? What documents do I need to bring? Will the doctors be unable to understand the reports because they are in Thai?" This is almost a real-world problem faced by everyone returning from overseas IVF. The following explains the choice of checkup location, process arrangement, medication transition, and risk prevention step by step.
1. Where should you go for follow-up checkups after returning from IVF in Thailand?
Direct answer: The first choice is the Reproductive Medicine Center of a tertiary hospital with assisted reproductive technology qualifications; the second choice is the Gynecology Clinic of a hospital of the same level (provided the doctor has experience in reproductive endocrinology). It is not recommended to have post-transfer follow-ups at general outpatient clinics without reproductive specialties, private clinics, or unregulated institutions. The core reason is that post-transfer follow-up involves dynamic monitoring of blood HCG, assessment of progesterone levels, interpretation of transvaginal ultrasound, and adjustment of luteal phase support medications, all of which require a doctor with a background in reproductive medicine.
When choosing a follow-up institution, you can refer to the following criteria: ① Whether the hospital is approved by the National Health Commission to perform assisted reproductive technology (can be checked on the NHC website); ② Whether it has an independent reproductive center or reproductive endocrinology department; ③ Whether it can prescribe commonly used luteal phase support medications such as dydrogesterone, progesterone injections, and progesterone vaginal gel; ④ Whether it has the laboratory capability for dynamic monitoring of blood HCG and progesterone; ⑤ Whether it can perform high-resolution transvaginal ultrasound.
2. Follow-up Process and Schedule
Post-transfer follow-up has specific time points, each corresponding to different examination purposes. The following is a standardized process (with D0 as the transfer day):
| Time Point | Test Item | Purpose and Significance |
|---|---|---|
| D12–D14 post-transfer | Blood HCG | Confirm pregnancy. If positive, continue luteal phase support; if negative, stop medication and arrange consultation for the next cycle. |
| D14–D16 post-transfer | Blood HCG + Progesterone | Assess early embryonic development trend and whether luteal function is adequate. If progesterone is low, adjust medication promptly. |
| D21–D23 post-transfer | Blood HCG (doubling test) | Rule out ectopic pregnancy risk and embryonic developmental delay. In normal pregnancy, HCG approximately doubles every 48–72 hours. |
| D28–D30 post-transfer | Transvaginal Ultrasound (+ Blood HCG, Progesterone) | Confirm gestational sac location (rule out ectopic pregnancy), number of gestational sacs, and fetal heartbeat. Visible fetal heartbeat at this stage indicates stable pregnancy. |
| D35–D42 post-transfer | Repeat Ultrasound + Hormones | Confirm sustained fetal heartbeat and that embryonic development matches gestational age. After this, gradual transition to routine obstetric checkups. |
Note: The above time points are based on D5 blastocyst transfer. For D3 cleavage-stage embryo transfer, each point should be 2–3 days earlier. The specific schedule should be based on the evaluation of the domestic attending physician.
3. Doctor's Perspective: Why Domestic Follow-up is Irreplaceable
From a clinical perspective, the core purposes of post-transfer follow-up are threefold: confirm pregnancy status, rule out abnormal pregnancy, and maintain luteal phase support. Thai hospitals usually only provide medication for 7–10 days post-transfer. After returning home, patients need to renew the prescription themselves. If the domestic attending physician is unaware of the patient's ovulation induction protocol in Thailand, embryo quality, transfer details, and medication history, it is easy for medication gaps or dosage errors to occur.
Additionally, the incidence of ectopic pregnancy in assisted pregnancies is about 2%–5%. It is difficult to completely rule out based solely on blood HCG levels in the early stage; it must be combined with ultrasound localization. If the follow-up institution lacks transvaginal ultrasound capabilities or the doctor lacks experience in identifying early ectopic pregnancy, diagnosis may be delayed. Therefore, choosing a hospital with a reproductive specialty background is not excessive caution but a safety baseline.
4. Differences Between the Thai and Domestic Follow-up Systems
In the Thai IVF process, post-transfer follow-up is usually jointly managed by embryologists and reproductive specialists. Medications primarily include imported progesterone vaginal gel and oral dydrogesterone. The types and formulations of medications available domestically differ slightly, and some imported medications may need to be switched to equivalent domestic preparations. The specific differences are as follows:
- Medication Transition: Thailand commonly uses Crinone gel (8%) or Utrogestan capsules. Domestically, commonly used medications include Xuenotong (same as Crinone), Yimaxin, progesterone injections, etc. An equivalent conversion should be made based on the availability of domestic pharmacies. Do not stop or change medication on your own.
- Test Standards: The reference range for blood HCG in Thailand differs slightly from that in China. Domestic doctors need to understand the reference values of the Thai laboratory to avoid misjudgment.
- Medical Record Language: Thai hospitals provide medical records in English or Thai. Domestic doctors need to be able to interpret them. It is recommended to request an English version of the medical summary from the Thai hospital before leaving Thailand, including key data (transfer date, embryo grade, medication protocol, hormone levels).
- Follow-up Habits: Domestic reproductive centers place greater emphasis on early ultrasound to confirm fetal heartbeat, whereas some Thai centers follow up only through blood HCG post-transfer, with lower ultrasound frequency. After returning home, ultrasound examinations should be completed according to domestic standards.
5. Most Easily Overlooked Details
The following details are often overlooked during the follow-up process but have a direct impact on pregnancy outcomes:
- Medical Record Translation and Notarization: Embryo culture reports and PGT results (if any) from Thai hospitals should ideally be translated into Chinese and stamped with the hospital's seal before leaving Thailand. Some domestic hospitals require notarized translations for acceptance.
- Calculating Remaining Medication: Before returning, ensure that the medication you bring can last until the first follow-up appointment. Progesterone vaginal gel requires refrigeration; use a portable cooler bag for long-distance transport.
- Establishing a File in Advance: Domestic reproductive centers usually require establishing a file during the first visit, needing your ID card, marriage certificate, and a summary of the Thai hospital medical records. It is recommended to complete the file within 3 days of returning home to avoid delaying the first follow-up.
- Hormone Test Unit Conversion: Thailand commonly uses mIU/mL (blood HCG) and ng/mL (progesterone). Some domestic hospitals use IU/L or nmol/L. Confirm the units during the consultation to avoid misreading the values.
- Informing About Drug Allergies: If you are allergic to progesterone injections (oil-based), inform the doctor in advance to switch to vaginal gel or oral formulations.
6. Most Common Pitfalls
Based on real situations encountered in clinical consultations, the following practices may pose risks:
- Having follow-ups at non-specialist clinics: General gynecology clinic doctors may not be familiar with luteal phase support protocols after assisted reproduction and may easily suggest "waiting a bit longer to check" or "stopping medication for observation," leading to luteal phase insufficiency and early miscarriage.
- Adjusting medication based on online information: Adding progesterone on your own upon seeing low blood HCG, or reducing medication upon seeing normal progesterone levels, lacks individualized basis.
- Skipping ultrasound: Only drawing blood without an ultrasound cannot rule out ectopic pregnancy or an empty gestational sac. There was a case where a patient had normal HCG doubling for 3 consecutive times, but an ultrasound revealed the gestational sac in the fallopian tube; timely detection avoided rupture and massive hemorrhage.
- Choosing a hospital that does not accept external medical records: A few hospitals do not recognize overseas assisted reproduction medical records, requiring "starting from scratch" or refusing consultation. It is advisable to call the hospital's reproductive center in advance to confirm if they accept overseas IVF patients.
- Delaying the first follow-up: Not having blood HCG tested more than 14 days post-transfer may miss the early intervention window (e.g., medical management of ectopic pregnancy).
7. Frequently Asked Questions
7.1 Do I have to go to a reproductive center after returning? Isn't a regular tertiary hospital gynecology department sufficient?
If the gynecologist has a subspecialty background in reproductive endocrinology and can prescribe luteal phase support medications, they can manage the follow-up. However, the gynecology departments in most general hospitals focus on gynecological oncology and pelvic floor disorders, with limited experience in post-assisted reproduction follow-up. It is recommended to prioritize a reproductive center. There are over 500 approved assisted reproduction institutions nationwide, covering most provincial capitals and major cities. You can check the list via "National Health Commission website → Medical Institutions → Assisted Reproductive Technology."
7.2 Can domestic doctors understand the full English medical records from Thai hospitals?
Most doctors in tertiary hospital reproductive centers can read English medical records. However, to ensure clear communication, it is recommended to request an English Summary from the Thai hospital before leaving Thailand and have a translation agency or friend help annotate key information (transfer date, embryo grade, medication protocol, hormone levels). Some hospitals require notarized translations; preparing in advance can avoid delays.
7.3 What if there is no reproductive center in my local area?
You can choose a reproductive center in a nearby city, or contact an experienced reproductive specialist for remote guidance through online consultation platforms. Meanwhile, have blood draws and ultrasounds done at a local tertiary hospital, and upload the reports to the guiding doctor for protocol adjustment. It is not recommended to rely entirely on a local non-specialist doctor to handle it independently.
7.4 How long do I need to use luteal phase support medications?
Generally, it continues until 10–12 weeks post-transfer (i.e., 10–12 weeks of gestation). After that, the placenta gradually takes over luteal function, and the medication can be gradually tapered under a doctor's guidance. The specific time to stop depends on the embryonic development indicated by ultrasound and hormone levels, with significant individual variation.
7.5 What should I do if blood HCG rises slowly during follow-up?
The doctor will assess the specific situation: if the absolute HCG value is low and doubling is poor, ectopic pregnancy or poor embryonic development should be considered; if the baseline HCG is high but the growth rate slows down, it needs to be evaluated in conjunction with ultrasound. Management options include close monitoring, adjusting luteal phase support, or surgical intervention (if ectopic pregnancy is confirmed). Do not use any miscarriage prevention medications or traditional Chinese medicine on your own.
8. Observations from Practitioners
In the clinic, we encounter many patients returning from overseas IVF for follow-up. A common issue is: unfamiliarity with the domestic medical system, underestimating the waiting time required for file establishment and appointments. Initial consultation slots at some well-known reproductive centers need to be booked 1–2 weeks in advance. If you start contacting the hospital only on the 10th day post-transfer, you may miss the optimal follow-up window. It is recommended to identify 1–2 target hospitals before going abroad, confirm the consultation process and required materials by phone or online platform, and take action immediately upon returning home.
Another observation is: the individualized conversion of luteal phase support protocols is crucial. The medications commonly used in Thailand do not have a one-to-one correspondence with domestic varieties, but equivalent alternatives are well-established. The attending physician needs to understand the patient's specific medication history (including dosage, frequency, and route of administration) to avoid a "medication gap." Patients should ideally request a detailed medication instruction from the Thai doctor before leaving, including suggestions for alternative protocols.
Suggestions for Next Steps: ① Confirm the list of assisted reproduction institutions in your city or nearby cities (check the NHC website); ② Call the target hospital's reproductive center in advance to ask if they accept overseas IVF patients, the required documents for file establishment, and the appointment lead time; ③ Organize the medical records, medication protocol, and test reports from the Thai hospital (prepare English + Chinese translations); ④ Calculate the first follow-up date based on the transfer day, and complete file establishment and appointment 1 week in advance.
This content is based on clinical routine and industry consensus in assisted reproduction and does not constitute personalized medical advice. Please follow the opinion of your attending physician for specific diagnosis and treatment plans. Author: Reproductive Specialist · Patient Education Material
